Evaluation of a provocative dyspnea severity score in acute heart failure. Am. Heart J. 2016, 172, 34-41. [CrossRef] [PubMed]Omar F. AbouEzzeddine, Anuradha Lala, Prateeti P. Khazanie, Ravi Shah, Jennifer E. Ho,
There was no association between ADR genotypes and New York Heart Association/Ross HF severity score. Regression analyses were performed to assess association of ADR genotypes with change in ventricular systolic and diastolic function on serial echocardiograms in 35 stable HF patients in whom serial ...
Join the 5th World Congress on Congestive Heart Failure and Angina to explore cutting-edge research, treatments, and global perspectives in cardiovascular health.
Methods: Seventy-eight DMD subjects underwent 211 cardiac magnetic resonance studies analyzed for left ventricular (LV) ejection fraction, indexed LV end diastolic and systolic volumes, circumferential strain, late gadolinium enhancement prese...
(ECG) variables18. Most of these variables are relevant to heart failure, and we hypothesized that this score might be associated with severity of disease and clinical outcomes in patients with established heart failure. Thus, we investigated whether the WATCH-DM score can predict prognosis in ...
The prognostic impact of ischaemic heart disease (IHD) on mortality in heart failure (HF) with reduced left ventricular ejection fraction (HFrEF) is incompletely elucidated. Two large randomized treatment trials of chronic HF...
Poses RM, McClish DK, Smith WR. et al. Results of report cards for patients with congestive heart failure depend on the method used to adjust for severity.Ann Intern Med.2000;133:10-20.http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?db=m&form=6&Dopt=r&uid=entrez/query.fcgi?
Acceptable: score = 3–4 if treated with a heart failure-specific beta-adrenergic antagonist and an ACE inhibitor, ARB, or ARNI, unless the patient has a documented intolerance to these agents. C. Optimal: score ≥5 if treated with a heart failure-specific beta-adrenergic antagonist and ...
results are not consistent. A propensity score–matched cohort study using the Swedish Heart Failure Registry showed a statistically significant, numerically larger survival of 45 compared to 42% after 5 years of β-blocker treatment in HFpEF patients (HR of 0.93,p = 0.04) [105]. However,...
With modern treatments for heart failure with reduced ejection fraction (EF), indicative of impaired cardiac systolic function, patients may exhibit an increase in EF. Limited data are available regarding the clinical management of this growing populatio